Gong M

No ORCID on file · 7 papers in corpus · active 2016-2025

Study types

  • case-report 1
  • rct 1

Condition tags

  • endometriosis 1
  • adenomyosis 1
2025
Journal of clinical and experimental hepatology ·doi:10.1016/j.jceh.2024.102459

The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rising due to rapid lifestyle changes. Although females may be less prone to MASLD than males, specific studies on MASLD in females should still be…

2025
Scientific reports ·doi:10.1038/s41598-025-18713-4

This study aims to investigate the association between multidimensional frailty phenotypes and recurrent pregnancy loss (RPL) in reproductive-aged women. This cross-sectional study analyzed data from 6,438 reproductive-aged women participat…

2023
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2023.100192

ObjectiveMyofascial tenderness is present in most chronic pelvic pain conditions and causes significant distress to patients. Treatment is challenging and often not curative. Cannabis is often used for self-management of chronic pelvic pain…

2023
Bioactive materials ·doi:10.1016/j.bioactmat.2022.08.026

It is of great importance to treat a bacterial-infected wound by a smart dressing capable of delivering antibiotics in a smart manner without causing drug resistance. The construction of smart release nanocontainers responsive to near-infra…

case-report 2023
Medicine ·doi:10.1097/md.0000000000033306

RATIONALE: Endometrial stromal sarcoma (ESS) is a rare disease in patients with uterine malignancies, accounting for <1%. Low-grade endometrial stromal sarcoma (LGESS) accounts merely 0.2% of gynecologic malignant tumor. Primary low-grade e…

2021
Frontiers in surgery ·doi:10.3389/fsurg.2021.760600

Background: There are few reports in the literature on the use of Glubran-2 for the embolization of ovarian veins in patients with pelvic venous disorder (PeVD). In addition, a consensus on the efficacy and safety of Glubran-2 has not been …

rct 2016
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.issn.0529-567X.2016.12.006

Objective: To investigate the value of using gonadotropin-releasing hormone agonist (GnRH-a) pretreatment in adenomyosis patients before adenomyomectomy. Methods: From May 2012 to September 2015, 87 patients with adenomyosis who were non-ef…